We report the biochemical hallmarks of tyrosine hydroxylase deficiency
with emphasis on reliable diagnostic strategies of four new cases of
an inborn error of tyrosine hydroxylase (TH). Three of our patients fr
om different parts of the Netherlands were found homozygous for a muta
tion in exon 6 (G698A) of the TH gene, and one patient was found compo
und heterozygous for the same mutation and an additional mutation in e
xon 3. The first clinical symptoms of hypokinesia, rigidity of arms an
d legs and axial hypotonia, developed between 3 and 7 months of age. C
erebrospinal fluid investigations revealed a characteristic metabolite
constellation in every case: low homovanillic acid (HVA) and 3-methox
y-4-hydroxyphenylethyleneglycol concentrations in the presence of norm
al reference range 5-hydroxyindolacetic acid concentrations. Strict ad
herence to a standardized lumbar puncture protocol and adequate age-re
lated reference values are essential for diagnosis of this ''new'' tre
atable neurometabolic disorder. Urinary measurements of HVA, vanillylm
andelic acid, and catecholamines can lead to false-negative conclusion
s. All patients showed a remarkable clinical improvement on a low dose
of ne/(S)-2-(3,4-dihydroxybenzyl)-2-hydrazinpropionic acid. During tr
eatment, cerebrospinal fluid HVA, and 3-methoxy-4-hydroxy-phenylethyle
neglycol increased substantially.